Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Dehydrocorydaline nitrate
Cat. No.:
OB0225LY-0442
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Dehydrocorydaline nitrate is a compound with analgesic and anti-inflammatory activity.
Synonym:
13005-09-9; Dehydrocorydaline (nitrate); 6H-Dibenzo[a,g]quinolizinium, 5-hydro-2,3,9,10-tetramethoxy-13-methyl-, nitrate (1:1); 2,3,9,10-Tetramethoxy-13-methyl-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium nitrate
CAS No.:
13005-09-9
Compound CID:
92043243
Formula:
C22H24N2O7
Formula Weight:
428.44
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Dehydrocorydaline nitrate can be used to study neuroprotective mechanisms or play an important role in models of neurodegenerative diseases.
Library Information
Targets:
Apoptosis regulatory proteins; Serine/Threonine kinases
Receptors:
p38 MAPK; PARP; Bax; Bcl-2; Caspase-7; Caspase-8
Pathways:
Autophagy; MAPK; Apoptosis; Chromatin/Epigenetic; DNA damage/DNA repair; Microbiology/Virology; Proteases/Proteasome
Plate Number:
AOCL-6
Plate Location:
f9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
27.5 mg/mL; 64.19 mM
Solubility:
Soluble in chloroform, dichloromethane, ethyl acetate, acetone, etc.
